Personalized cancer vaccine shows promise against melanoma
A personalized cancer vaccine combined with pembrolizumab reduced melanoma recurrence in a late-stage trial, drugmakers said, advancing tailored therapies.
A personalized cancer vaccine combined with pembrolizumab reduced melanoma recurrence in a late-stage trial, drugmakers said, advancing tailored therapies.